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The annual Genomic Disorders conference was held in
March 2009 at the Sanger Center Genome Campus in
Hinxton, UK. The scientific program was developed by Nigel
Carter (Wellcome Trust Sanger Institute, Hinxton, UK),
Dian Donnai (University of Manchester, UK), Helen Firth
(Cambridge University, UK) and James Lupski (Baylor
College of Medicine, Houston, TX, USA). This meeting
covered mechanisms of genomic instability and genomic
variation in common disease, brain disorders, X-
chromosome disorders, and rare syndromes, as well as
bioinformatics approaches, modeling approaches, and an
evolutionary perspective on genomic disorders, appealing to
clinicians as well as basic researchers. Across this wide
variety of topics, several themes emerged in this recently
revitalized field.
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The mechanisms of genomic rearrangements are diverse,
and dissection of the sequence data at breakpoints can give
clues as to the underlying mechanisms. James Lupski
started the meeting with a presentation focused on the
mechanisms and detection of genomic rearrangements and
copy number variants (CNVs). These can be classified as
recurrent (with clustered breakpoints, usually within low
copy repeats), non-recurrent with breakpoint grouping, and
non-recurrent with little overlap. Several mechanisms
underlie these classes of events: non-allelic homologous
recombination (NAHR) occurs between highly homologous
low copy repeats and often results in recurrent
rearrangements. Non-homologous end joining (NHEJ) and
fork stalling and template switching (FoSTeS) can result in
non-recurrent events. NHEJ often leaves 'scars' at the site of
rearrangement, including deletion or addition of
nucleotides, and frequently occurs at repetitive elements or
known sequence motifs, and FoSTeS often shows evidence of
microhomology (for example, 2-4 base pairs) and can most
simply explain complex forms of rearrangement. All of these
mechanisms can occur in meiosis or mitosis. The differences
in mechanism suggest that the rates of these events may vary
widely across the genome, dependent on local architecture,
which has implications for population and evolutionary
genetics, as well as models for disease association.
These themes were touched on during other talks during the
conference, including those given by Alec Jeffreys
(University of Leicester, UK) focusing on hotspots of
recombination and NAHR at the beta-globin locus as
explored by sperm typing; Peter Campbell (Wellcome Trust
Sanger Institute, Hinxton, UK) on patterns in somatic
genomic rearrangements in cancer; and Lisenka Vissers
(Radboud University Nijmegen Medical Centre, The
Netherlands), who provided an analysis of microhomology,
repetitive elements and sequence motifs present in 38 rare
pathogenic CNVs ascertained clinically. Matthew Hurles(Wellcome Trust Sanger Institute, Hinxton, UK) reported
that in the Wellcome Trust Case Control Consortium
(WTCCC) study of common diseases and a common pool of
controls, 30-40% of events were mediated by NHEJ and an
equal proportion showed microhomology; approximately
15% were variable number tandem repeats, 7% mediated by
NAHR and less than 1% events of retrotransposition.
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Few dramatic successes have been made in identifying the
contribution of CNV to common disease; in contrast, there has
been much success in identifying causal genomic variants in
rare disorders and in brain disorders; however, the underlying
pathophysiological mechanisms are rarely obvious.
Matthew Hurles reported that in the WTCCC, there is no
strong evidence for a greater rare CNV burden in disease
cases versus controls or in any particular disease studied.
He also observed a null distribution for common CNVs that
could be detected. However, in many regions of single
nucleotide polymorphism (SNP) association, there are
CNVs in linkage disequilibrium with SNPs that could be
the causative variation in those instances. Timothy Aitman
(MRC Clinical Sciences Centre and Imperial College
London, UK) and John Armour (University of Nottingham,
UK) presented CNVs implicated in autoimmune disease,
and Dr Armour discussed the technical challenges involved
in genotyping multi-allelic and complex CNVs.
Doug Higgs (Oxford and National Haemoglobinopathy
Reference Laboratory, Churchill Hospital, UK) emphasized
CNV effects on flanking genes lying outside of the CNV
region, including long-range effects. Similarly, position
effects were observed in rare congenital malformations, as
discussed by David Fitzpatrick (MRC Human Genetics
Unit and Institute for Genetic and Molecular Medicine
Western General Hospital, Edinburgh, UK) and Eva
Klopocki (Institute of Medical Genetics, Charité
Universitätsmedizin, Berlin, Germany) with regard to
SOX9, and Pawel Stankiewicz (Baylor College of Medicine,
Houston, TX, USA) with regard to FOXF1. In several cases,
very similar phenotypes were observed with adjacent, but
non-overlapping deletions in both novel and known
syndromes; this was discussed by Harmut Engels
(Rheinische Friedrick-Wilhelms-University, Bonn,
Germany) and Femke Hannes (Center for Human
Genetics, Katholieke Universiteit, Leuven, Belgium),
respectively.
Several speakers in the session on brain disorders noted the
wide expressivity of even highly penetrant CNVs, including
shared etiology between schizophrenia, autism, mental
retardation and epilepsy (Lauren Weiss, University of
California San Francisco, CA, USA and Audrey Guilmatre,
Inserm, Rouen, France). For this reason, the approach of
reverse genomics/genetics was proposed in presentations
by James Lupski and Lauren Weiss, in order to, for
example, ascertain subjects with the same CNV and then
look for common phenotypic manifestations. Helen Firth
presented DECIPHER, a bioinformatics approach to assign
a phenotype to genes or genomic regions by analysis of rare
pathogenic mutations and syndromes.
Leon-Charles Tranchevent (Katholieke Universiteit
Leuven, Belgium), Daniela Nitsch (Katholieke Universiteit
Leuven, Belgium) and Caleb Webber (University of Oxford,
UK) proposed bioinformatics approaches to identifying
candidate genes of interest for specific phenotypes within
large genomic rearrangements. A presentation by Maria
Karayiorgou (Columbia University, New York, NY, USA) on
mouse models of human 22q11 deletion attempting to
explain the psychiatric phenotypes in human patients re-
emphasized the complexity of disease-causing
mechanisms. Single gene knock-outs of several genes in
the region have been shown to cause murine phenotypes
reminiscent of the cognitive deficits associated with
schizophrenia in patients.
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The identification and characterization of genomic variation
has recently enjoyed much success due to high-resolution
microarrays and next-generation sequencing technology.
We know much more about the mechanisms and population
and evolutionary characteristics of these events and we
have identified many novel disease loci as compared with
just a few years ago. However, this dramatic increase in the
depth of our understanding of genomic rearrangements has
only emphasized that we still have much to learn about the
spectrum of human genomic variation and the biological
and clinical implications thereof. In the immediate future,
further optimization of approaches for detection,
genotyping, and analysis - particularly for small, complex,
and common variants - could improve our ability to detect
low-penetrance contribution to human disease and
population variation. Looking forward, our clinical
interpretation and biological investigation must keep pace
with these myriad novel genomic discoveries.
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CNV, copy number variant; FoSTeS, fork stalling and
template switching; NAHR, non-allelic homologous
recombination; NHEJ, non-homologous end joining; SNP,
single nucleotide polymorphism; WTCCC, Wellcome Trust
Case Control Consortium.
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